Advertisement

Alachua biotech company receives $42 million contract from DOD

Ology Bioservices, a vaccine and biologic company, was awarded a contract of up to $42 million to continue developing an antibody to Botulism.
Ology Bioservices, a vaccine and biologic company, was awarded a contract of up to $42 million to continue developing an antibody to Botulism.(WCJB)
Published: Jul. 2, 2020 at 4:17 AM EDT
Email this link
Share on Pinterest
Share on LinkedIn

GAINESVILLE, Fla. (WCJB) - A biotech company based in Alachua has won a large contract from the Department of Defense.

Ology Bioservices, a vaccine and biologic company, was awarded a contract of up to $42 million to continue developing an antibody to Botulism.

It’s part of the DOD’s joint program for chemical, biological, radiological and nuclear defense. Ology will perform a clinical trial on the antibodies and develop its manufacturing process. Their scientists have been working on the process since 2017.

Copyright 2020 WCJB. All rights reserved.

Latest News

Latest News